Patients with pancreatic ductal adenocarcinoma were shown to have excessive levels of IGFBP-1, 3, IGF2BP-2, IGF-1, and IGF1R in their blood and pancreatic cells [42,43]. Here, IGF1R is linked to pancreatic ductal adenocarcinoma.